EMEIS SA (EMEIS.PA) Stock Fundamental Analysis
Europe - EPA:EMEIS - FR001400NLM4 - Common Stock
14.31 EUR
-0.27 (-1.85%)
EMEIS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. EMEIS has a bad profitability rating. Also its financial health evaluation is rather negative. EMEIS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year EMEIS has reported negative net income.
EMEIS had a positive operating cash flow in the past year.
In multiple years EMEIS reported negative net income over the last 5 years.
In the past 5 years EMEIS always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -3.07%, EMEIS is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
The Return On Equity of EMEIS (-23.89%) is worse than 88.89% of its industry peers.
The Return On Invested Capital of EMEIS (0.03%) is worse than 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROIC | 0.03% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EMEIS has a Operating Margin of 0.08%. This is amonst the worse of the industry: EMEIS underperforms 85.19% of its industry peers.
EMEIS's Operating Margin has declined in the last couple of years.
EMEIS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
EMEIS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, EMEIS has more shares outstanding
The number of shares outstanding for EMEIS has been reduced compared to 5 years ago.
Compared to 1 year ago, EMEIS has a worse debt to assets ratio.
2.2 Solvency
EMEIS has an Altman-Z score of 0.63. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EMEIS (0.63) is worse than 66.67% of its industry peers.
EMEIS has a debt to FCF ratio of 51.23. This is a negative value and a sign of low solvency as EMEIS would need 51.23 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 51.23, EMEIS is doing worse than 74.07% of the companies in the same industry.
A Debt/Equity ratio of 4.80 is on the high side and indicates that EMEIS has dependencies on debt financing.
EMEIS has a Debt to Equity ratio of 4.80. This is amonst the worse of the industry: EMEIS underperforms 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.01
WACC4.71%
2.3 Liquidity
A Current Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.
EMEIS has a worse Current ratio (0.62) than 77.78% of its industry peers.
EMEIS has a Quick Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
EMEIS's Quick ratio of 0.62 is on the low side compared to the rest of the industry. EMEIS is outperformed by 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
EMEIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.53%.
Looking at the last year, EMEIS shows a small growth in Revenue. The Revenue has grown by 6.30% in the last year.
The Revenue has been growing by 8.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
3.2 Future
EMEIS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.92% yearly.
Based on estimates for the next years, EMEIS will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y24.08%
EPS Next 2Y24.28%
EPS Next 3Y21.78%
EPS Next 5Y17.92%
Revenue Next Year4.84%
Revenue Next 2Y4.72%
Revenue Next 3Y4.75%
Revenue Next 5Y2.7%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EMEIS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EMEIS indicates a rather expensive valuation: EMEIS more expensive than 85.19% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMEIS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.24 | ||
| EV/EBITDA | 22.65 |
4.3 Compensation for Growth
EMEIS's earnings are expected to grow with 21.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.28%
EPS Next 3Y21.78%
5. Dividend
5.1 Amount
EMEIS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:EMEIS (10/31/2025, 7:00:00 PM)
14.31
-0.27 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners56.3%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.31B
Revenue(TTM)5.77B
Net Income(TTM)-412065000
Analysts75.38
Price Target12.34 (-13.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-98.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.41 | ||
| P/FCF | 13.24 | ||
| P/OCF | 4.89 | ||
| P/B | 1.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.65 |
EPS(TTM)-1.8
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)1.08
FCFY7.55%
OCF(TTM)2.92
OCFY20.43%
SpS34.91
BVpS10.68
TBVpS-7.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 3.1% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.23%
ROICexgc growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Debt/EBITDA | 17.9 | ||
| Cap/Depr | 64.95% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.08% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.63 |
F-Score4
WACC4.71%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
EPS Next Y24.08%
EPS Next 2Y24.28%
EPS Next 3Y21.78%
EPS Next 5Y17.92%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year4.84%
Revenue Next 2Y4.72%
Revenue Next 3Y4.75%
Revenue Next 5Y2.7%
EBIT growth 1Y103.51%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10732.9%
EBIT Next 3Y416.71%
EBIT Next 5Y253.09%
FCF growth 1Y293.3%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y28.92%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%
EMEIS SA / EMEIS.PA FAQ
What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?
ChartMill assigns a fundamental rating of 1 / 10 to EMEIS.PA.
What is the valuation status for EMEIS stock?
ChartMill assigns a valuation rating of 1 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.
What is the profitability of EMEIS stock?
EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.
Can you provide the financial health for EMEIS stock?
The financial health rating of EMEIS SA (EMEIS.PA) is 0 / 10.
Can you provide the dividend sustainability for EMEIS stock?
The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.